CO-338-063: TRITON3: A Multicenter, Randomized, Open Label Phase 3 Study of Rucaparib Versus Physician's Choice of Therapy for Patients With Metastatic Castration Resistant Prostate Cancer Associated With Homologous Recombination Deficiency

February 19, 2019
https://clinicaltrials.gov/ct2/results?id=NCT02975934
Cancer - Prostate
Principal Investigator: Sheela Tejwani, MD
Cancer, Prostate Cancer, GU, Phase 3, Phase III
Open